Treatment with unsealed source radiation involves the administration of soluble forms of radioactive substances. This type of treatment is administered either orally or via injection, but is only used to treat very specific types of cancer. For example, patients with thyroid cancer are often treated with a solution of radioactive iodine.
One major disadvantage of unsealed source radiation therapy is that people who receive this treatment are considered to be radioactive for the duration of the treatment and for several weeks after - this means they can actually pose a health risk to other people. Note that this is not a treatment that is used for patients with mesothelioma.
Sources:
- Dodson, R. and Hammar, S. Asbestos: Risk Assessment, Epidemiology, and Health Effects. Taylor & Francis: Boca Raton. 2006.
- Galateau-Salle, Francoise. Pathology of Malignant Mesothelioma. Springer-Verlag London Limited: London. 2006.
- Pass, I., Vogelzang, N., Carbone, M. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Transitional Therapies. Springer: New York. 2005.
- http://www.cancer.org/downloads/PUB/DOCS/SECTION28/89.pdf
- http://www.americanbrachytherapy.org/aboutBrachytherapy/BrachyFAQFinal2.pdf
No comments:
Post a Comment